322 related articles for article (PubMed ID: 33481148)
1. Local failure after stereotactic radiosurgery (SRS) for intracranial metastasis: analysis from a cooperative, prospective national registry.
Asher AL; Alvi MA; Bydon M; Pouratian N; Warnick RE; McInerney J; Grills IS; Sheehan J
J Neurooncol; 2021 Apr; 152(2):299-311. PubMed ID: 33481148
[TBL] [Abstract][Full Text] [Related]
2. Stereotactic radiosurgery to the resection bed for intracranial metastases and risk of leptomeningeal carcinomatosis.
Ojerholm E; Lee JY; Thawani JP; Miller D; O'Rourke DM; Dorsey JF; Geiger GA; Nagda S; Kolker JD; Lustig RA; Alonso-Basanta M
J Neurosurg; 2014 Dec; 121 Suppl():75-83. PubMed ID: 25434940
[TBL] [Abstract][Full Text] [Related]
3. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
[TBL] [Abstract][Full Text] [Related]
4. Factors associated with progression and mortality among patients undergoing stereotactic radiosurgery for intracranial metastasis: results from a national real-world registry.
Alvi MA; Asher AL; Michalopoulos GD; Grills IS; Warnick RE; McInerney J; Chiang VL; Attia A; Timmerman R; Chang E; Kavanagh BD; Andrews DW; Walter K; Bydon M; Sheehan JP
J Neurosurg; 2022 Oct; 137(4):985-998. PubMed ID: 35171833
[TBL] [Abstract][Full Text] [Related]
5. Stereotactic radiosurgery in the management of non-small cell lung cancer brain metastases: a prospective study using the NeuroPoint Alliance Stereotactic Radiosurgery Registry.
Michalopoulos GD; Katsos K; Grills IS; Warnick RE; McInerney J; Attia A; Timmerman R; Chang E; Andrews DW; D'Ambrosio AL; Cobb WS; Pouratian N; Spalding AC; Walter K; Jensen RL; Bydon M; Asher AL; Sheehan JP
J Neurosurg; 2024 May; 140(5):1223-1232. PubMed ID: 37948684
[TBL] [Abstract][Full Text] [Related]
6. Early Gamma Knife stereotactic radiosurgery to the tumor bed of resected brain metastasis for improved local control.
Iorio-Morin C; Masson-Côté L; Ezahr Y; Blanchard J; Ebacher A; Mathieu D
J Neurosurg; 2014 Dec; 121 Suppl():69-74. PubMed ID: 25434939
[TBL] [Abstract][Full Text] [Related]
7. Radiosurgery in the management of brain metastasis: a retrospective single-center study comparing Gamma Knife and LINAC treatment.
Tuleasca C; Negretti L; Faouzi M; Magaddino V; Gevaert T; von Elm E; Levivier M
J Neurosurg; 2018 Feb; 128(2):352-361. PubMed ID: 28338441
[TBL] [Abstract][Full Text] [Related]
8. Local tumor response and survival outcomes after combined stereotactic radiosurgery and immunotherapy in non-small cell lung cancer with brain metastases.
Singh C; Qian JM; Yu JB; Chiang VL
J Neurosurg; 2019 Feb; 132(2):512-517. PubMed ID: 30771783
[TBL] [Abstract][Full Text] [Related]
9. Stereotactic radiosurgery boost to the resection bed for oligometastatic brain disease: challenging the tradition of adjuvant whole-brain radiotherapy.
Karlovits BJ; Quigley MR; Karlovits SM; Miller L; Johnson M; Gayou O; Fuhrer R
Neurosurg Focus; 2009 Dec; 27(6):E7. PubMed ID: 19951060
[TBL] [Abstract][Full Text] [Related]
10. Survival after surgery and stereotactic radiosurgery for patients with multiple intracranial metastases: results of a single-center retrospective study.
Smith TR; Lall RR; Lall RR; Abecassis IJ; Arnaout OM; Marymont MH; Swanson KR; Chandler JP
J Neurosurg; 2014 Oct; 121(4):839-45. PubMed ID: 24857242
[TBL] [Abstract][Full Text] [Related]
11. Stereotactic radiosurgery for patients with multiple brain metastases: a case-matched study comparing treatment results for patients with 2-9 versus 10 or more tumors.
Yamamoto M; Kawabe T; Sato Y; Higuchi Y; Nariai T; Watanabe S; Kasuya H
J Neurosurg; 2014 Dec; 121 Suppl():16-25. PubMed ID: 25434933
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of conformity index and gradient index in patients undergoing stereotactic radiosurgery for a single metastatic tumor.
Aiyama H; Yamamoto M; Kawabe T; Watanabe S; Koiso T; Sato Y; Higuchi Y; Ishikawa E; Yamamoto T; Matsumura A; Kasuya H
J Neurosurg; 2018 Dec; 129(Suppl1):103-110. PubMed ID: 30544326
[TBL] [Abstract][Full Text] [Related]
13. Repeat stereotactic radiosurgery as salvage therapy for locally recurrent brain metastases previously treated with radiosurgery.
McKay WH; McTyre ER; Okoukoni C; Alphonse-Sullivan NK; Ruiz J; Munley MT; Qasem S; Lo HW; Xing F; Laxton AW; Tatter SB; Watabe K; Chan MD
J Neurosurg; 2017 Jul; 127(1):148-156. PubMed ID: 27494815
[TBL] [Abstract][Full Text] [Related]
14. Changing practice patterns of Gamma Knife versus linear accelerator-based stereotactic radiosurgery for brain metastases in the US.
Park HS; Wang EH; Rutter CE; Corso CD; Chiang VL; Yu JB
J Neurosurg; 2016 Apr; 124(4):1018-24. PubMed ID: 26473783
[TBL] [Abstract][Full Text] [Related]
15. Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial.
Brown PD; Ballman KV; Cerhan JH; Anderson SK; Carrero XW; Whitton AC; Greenspoon J; Parney IF; Laack NNI; Ashman JB; Bahary JP; Hadjipanayis CG; Urbanic JJ; Barker FG; Farace E; Khuntia D; Giannini C; Buckner JC; Galanis E; Roberge D
Lancet Oncol; 2017 Aug; 18(8):1049-1060. PubMed ID: 28687377
[TBL] [Abstract][Full Text] [Related]
16. Follow-up results of brain metastasis patients undergoing repeat Gamma Knife radiosurgery.
Koiso T; Yamamoto M; Kawabe T; Watanabe S; Sato Y; Higuchi Y; Yamamoto T; Matsumura A; Kasuya H
J Neurosurg; 2016 Dec; 125(Suppl 1):2-10. PubMed ID: 27903177
[TBL] [Abstract][Full Text] [Related]
17. Does size matter? Investigating the optimal planning target volume margin for postoperative stereotactic radiosurgery to resected brain metastases.
Jhaveri J; Chowdhary M; Zhang X; Press RH; Switchenko JM; Ferris MJ; Morgan TM; Roper J; Dhabaan A; Elder E; Eaton BR; Olson JJ; Curran WJ; Shu HG; Crocker IR; Patel KR
J Neurosurg; 2018 Apr; 130(3):797-803. PubMed ID: 29676690
[TBL] [Abstract][Full Text] [Related]
18. Adverse radiation effect after stereotactic radiosurgery for brain metastases: incidence, time course, and risk factors.
Sneed PK; Mendez J; Vemer-van den Hoek JG; Seymour ZA; Ma L; Molinaro AM; Fogh SE; Nakamura JL; McDermott MW
J Neurosurg; 2015 Aug; 123(2):373-86. PubMed ID: 25978710
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors for melanoma brain metastases treated with stereotactic radiosurgery.
Bian SX; Routman D; Liu J; Yang D; Groshen S; Zada G; Trakul N; Wong MK; Yu C; Chang EL
J Neurosurg; 2016 Dec; 125(Suppl 1):31-39. PubMed ID: 27903181
[TBL] [Abstract][Full Text] [Related]
20. Application of recursive partitioning analysis and evaluation of the use of whole brain radiation among patients treated with stereotactic radiosurgery for newly diagnosed brain metastases.
Chidel MA; Suh JH; Reddy CA; Chao ST; Lundbeck MF; Barnett GH
Int J Radiat Oncol Biol Phys; 2000 Jul; 47(4):993-9. PubMed ID: 10863070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
